Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Board Update

14 Jun 2022 07:00

RNS Number : 7232O
Calnex Solutions PLC
14 June 2022
Β 

14 June 2022

Calnex Solutions plc

("Calnex" or the "Company")

Board Update

Β 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications sector, announces that following nine years as Chair of the Board of Calnex, George Elliott has taken the decision to retire from his position on the Board of Directors and will not seek re-election at the Company's 2022 AGM. The Company is pleased to confirm that current Non-Executive Director, Stephen Davidson, has been appointed as Chair Designate and will succeed George at the conclusion of the AGM on 17 August 2022.

Β 

Stephen Davidson joined the Board of Calnex in January 2022 and is an accomplished director of both public and private companies, with more than 20 years' PLC-board experience. He has previously acted as Chair at AIM-traded companies Actual Experience plc, RBG Holdings plc and Jaywing plc and at JSE-listed Datatec plc.

Β 

George Elliott, Chair of Calnex, commented, "When I joined Tommy and the team in 2013 it was evident to me that the future for Calnex was an exciting one. It has been an honour to help guide the business through its subsequent growth and journey onto the public markets. I am confident there is a strong Board and management team in place and with its outstanding customer base, the ongoing transition of the telecoms industry to 5G and the growth in cloud computing, the future for Calnex is brighter than ever."

Β 

Tommy Cook, CEO of Calnex, commented, "George has been a huge support to me over the past nine years and I and the whole Company thank him for his service and wish him all the very best. Our new Directors, Stephen and Margaret Rice-Jones who joined us in January, have quickly become valued colleagues and we have benefitted from their extensive experience and knowledge. I look forward to continuing to work with them both and the wider Board to drive Calnex forward."

Β 

For more information, please contact:

Β 

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cenkos Securities plc - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

Β 

Alma PR

+ 44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli

Β 

Β 

Overview of Calnex

Β 

Calnex Solutions designs, produces and markets test and measurement instrumentation and solutions for the telecoms and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enablingΒ its customers toΒ validateΒ the performance of the critical infrastructure associated withΒ telecoms and cloud computingΒ networks and the applications that run on it.

Β 

To date,Β CalnexΒ has secured and delivered ordersΒ toΒ overΒ 680Β customer sites inΒ 68 countries across the world.Β Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

Β 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distributionΒ capability.Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABKNBKKBKBKAD
Date   Source Headline
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.